Clinical Trial Update: A Study of Vedolizumab in People With Ulcerative Colitis and Crohn's Disease [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating vedolizumab in ulcerative colitis and Crohn's disease has completed and results have been posted by Takeda.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Ulcerative Colitis

Drugs mentioned

• Vedolizumab (Entyvio) (Vedolizumab)

Snippet

Sponsor: Takeda | Conditions: Ulcerative Colitis, Crohn Disease | Phase 4 | Status: COMPLETED | Results posted: 2025-02-12